Compounds > bromocriptine
Page last updated: 2024-08-23

bromocriptine and Adenoma, beta-Cell

bromocriptine has been researched along with Adenoma, beta-Cell in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Leeuw van Weenen, JE; Guigas, B; Havekes, LM; Maechler, P; Ouwens, DM; Parlevliet, ET; Pijl, H; Romijn, JA1
De Herder, WW; Hofland, LJ; Kros, MJ; Lamberts, SW; Uitterlinden, P; Van Koetsveld, PM; Van Uffelen, C; Visser-Wisselaar, HA; Waaijers, M; Zuyderwijk, J1
de Herder, WW; Hofland, LJ; Lamberts, SW; Uitterlinden, P; van Koetsveld, PM; Waaijers, M; Zuijderwijk, J1

Other Studies

3 other study(ies) available for bromocriptine and Adenoma, beta-Cell

ArticleYear
The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cells.
    Biochemical pharmacology, 2010, Jun-15, Volume: 79, Issue:12

    Topics: Animals; Bromocriptine; Cell Line; Dopamine Agonists; Dose-Response Relationship, Drug; Glucose; Insulin; Insulin Secretion; Insulin-Secreting Cells; Insulinoma; Male; Mice; Mice, Inbred C57BL; Rats; Receptors, Adrenergic, alpha; Receptors, Dopamine D2

2010
Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors.
    The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:9

    Topics: Adenoma; Adenoma, Islet Cell; Aminoquinolines; Bromocriptine; Dopamine Agonists; Endocrine Gland Neoplasms; Hormone Antagonists; Hormones; Humans; Insulinoma; Pancreatic Neoplasms; Pituitary Neoplasms; Prolactinoma; Receptors, Somatostatin; Somatostatin; Tumor Cells, Cultured

1997
Interferon-alpha-2a is a potent inhibitor of hormone secretion by cultured human pituitary adenomas.
    The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:9

    Topics: Adenoma; Bromocriptine; Dopamine Agonists; Gastrinoma; Gastrins; Human Growth Hormone; Humans; Insulin; Insulin Secretion; Insulinoma; Interferon alpha-2; Interferon-alpha; Octreotide; Pancreatic Neoplasms; Pituitary Neoplasms; Prolactin; Prolactinoma; Recombinant Proteins; Somatostatin; Tumor Cells, Cultured

1999